COCHEnvoy Medical, Inc.同业对比
Envoy Medical, Inc. 与SIC 3842 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COCH本股 | $56M#8 | — | 17.1x#12 | 233.8x#12 | 7.1%#4 | -14.2%#8 | -9240.7%#13 | -719.2%#14 | — | — | -42.5%#11 | 3.2%#1 |
| AVR | $813M#1 | — | 3.2x#6 | 425.1x#13 | -29.2%#13 | -23.4%#9 | -4908.2%#12 | -37.4%#7 | — | — | 43.8%#2 | — |
| SMTI | $322M#2 | — | 40.6x#14 | 3.1x#6 | 19.0%#2 | 288.7%#1 | 7.1%#1 | 472.9%#1 | 17.4%#1 | 6#1 | 0.9%#5 | — |
| INGN | $138M#3 | — | 0.8x#2 | 0.5x#2 | 5.9%#5 | -36.6%#10 | -10.2%#5 | 13.0%#3 | -34.4%#3 | 4#2 | -39.3%#9 | — |
| CNXU | $126M#4 | — | 21.5x#13 | — | — | — | — | 0.0%#5 | — | — | — | — |
| LAKE | $104M#5 | — | 0.8x#4 | 0.5x#3 | 15.2%#3 | -40.0%#11 | -8.1%#4 | -20.2%#6 | -15.4%#2 | 3#4 | -27.2%#7 | 1.1%#2 |
| SPAI | $89M#6 | — | 7.4x#8 | 146.3x#11 | -72.0%#14 | -92.8%#12 | -2397.6%#11 | -119.6%#10 | -771.1%#7 | 4#2 | -41.2%#10 | — |
| NTRB | $84M#7 | — | 15.8x#11 | 41.3x#10 | -4.8%#11 | 21.5%#3 | -408.4%#8 | -154.4%#11 | -212.9%#5 | — | -3.4%#6 | — |
| APT | $53M#9 | 13.4x#1 | 0.8x#3 | 0.9x#4 | 2.3%#7 | -10.3%#7 | 6.5%#2 | 5.4%#4 | — | — | 7.5%#3 | — |
| MYO | $50M#10 | — | 8.5x#9 | 1.2x#5 | 25.7%#1 | -151.6%#13 | -35.2%#6 | -267.6%#13 | — | — | 44.3%#1 | — |
| MLSS | $36M#11 | — | 10.4x#10 | 4.0x#8 | 4.0%#6 | 21.4%#5 | -63.5%#7 | 164.9%#2 | — | — | -32.4%#8 | — |
| BBLGW | $25M#12 | — | 6.2x#7 | 0.0x#1 | 0.0%#8 | 24.4%#2 | -0.3%#3 | -79.2%#9 | — | — | -88.9%#13 | — |
| HSCS | $16M#13 | — | — | 3723.2x#14 | -0.7%#10 | -4.3%#6 | -194787.4%#14 | — | — | — | 2.4%#4 | — |
| NTRBW | $12M#14 | — | 2.2x#5 | 5.7x#9 | -4.8%#11 | 21.5%#3 | -408.4%#8 | -154.4%#11 | -212.9%#5 | — | -43.2%#12 | — |
| FEED | $10M#15 | — | 0.3x#1 | 3.8x#7 | -0.2%#9 | -390.8%#14 | -896.6%#10 | -59.1%#8 | -74.0%#4 | — | -98.9%#14 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议